Enter your login e-mail to the account
Search
Search parameters
Search results
- Differential diagnosis of lymphadenopathy and lymphocytosis, indolent lymphomas
MUDr. Miloš Nosáľ, PhD.
(6/2014, Oncohematology Review ) - Waldenström’s macroglobulinemia in 2016: in order to optimize immunochemotherapy minimizing side effects
MUDr. Michal Kaščák, Mgr. Zuzaná Kufová, Mgr. Kateřina Growková, prof. MUDr. Roman Hájek, CSc.
(5/2016, Spectrum ) - Classification and diagnostics of indolent B-cell neoplasms in the context of the new WHO classification 2016
MUDr. Tomáš Balhárek, PhD., prof. MUDr. Lukáš Plank, CSc.
(2/2017, Spectrum ) - WALDENSTRÖM‘S MACROGLOBULINEMIA – EPIDEMIOLOGY, ETHIOPATOGENESIS, DIAGNOSTIC AND TREATMENT
prof. MUDr. Elena Tóthová, CSc.
(5/2008, Review articles ) - Waldenström‘s macroglobulinemia and treatment
MUDr. Radoslav Greksák, PhD.
(1/2019, Review articles ) - Acalabrutinib, a new Bruton's tyrosine kinase inhibitor in first line CLL treatment
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD.
(2/2023, Review articles ) - Ibrutinib in treatment of Waldenström´s makroglobulinemia – case report
MUDr. Aneta Matysová
(4/2017, Original articles & case reports )